Insider Trading: Hi-Tech Pharmacal Co Inc (HITK.O)
HITK.O on Nasdaq
33.74USD
21 May 2013
33.74USD
21 May 2013
Price Change (% chg)
$0.79 (+2.40%)
$0.79 (+2.40%)
Prev Close
$32.27
$32.27
Open
$33.06
$33.06
Day's High
$33.94
$33.94
Day's Low
$32.69
$32.69
Volume
40,320
40,320
Avg. Vol
60,900
60,900
52-wk High
$38.17
$38.17
52-wk Low
$27.35
$27.35
HIRSHAUT YASHAR
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 4 Nov 2012 | Buy | 11,250 | $8.31 | 45,500 |
| 5 Oct 2011 | Buy | 11,250 | $4.29 | 34,250 |
Institutional Holders
| % Shares Owned: | 72.98% |
| # of Holders: | 139 |
| Total Shares Held: | 9,904,130 |
| 3 Mo. Net Change: | -29,449 |
| # New Positions: | 15 |
| # Closed Positions: | 15 |
| # Increased Positions: | 63 |
| # Reduced Positions: | 52 |
| # Net Buyers: | 11 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
David Seltzer |
52 | 2004 | Chairman of the Board, President, Chief Executive Officer, Secretary, Treasurer |
Reuben Seltzer |
56 | 2010 | Vice Chairman of the Board |
William Peters |
45 | 2004 | Chief Financial Officer, Vice President |
Gary April |
55 | 1998 | President - Health Care Products Division |
Cameron Durrant |
52 | 2013 | President and Chief Executive Officer of ECR Pharmaceutical Co., Inc. |
Kamel Egbaria |
54 | 2010 | Executive Vice President, Chief Scientific Officer |
Martin Goldwyn |
60 | 1992 | Director |
Yashar Hirshaut |
74 | 1992 | Independent Director |
Anthony Puglisi |
63 | 2005 | Independent Director |
Bruce Simpson |
70 | 2005 | Independent Director |
Jack Van Hulst |
73 | 2008 | Independent Director |
Anne Siebert |
Investor Relations Officer |

